ROYAL BANK OF CANADA - SORRENTO THERAPEUTICS INC ownership

SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 212 filers reported holding SORRENTO THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.50 and the average weighting 0.3%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of SORRENTO THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$64,000
+300.0%
71,411
+565.3%
0.00%
Q3 2022$16,000
-20.0%
10,734
+7.6%
0.00%
Q2 2022$20,000
-77.3%
9,977
-73.9%
0.00%
Q1 2022$88,000
-90.7%
38,231
-81.2%
0.00%
Q4 2021$946,000
+142.6%
203,315
+297.8%
0.00%
Q3 2021$390,000
+4.8%
51,109
+33.3%
0.00%
Q2 2021$372,000
+19.6%
38,342
+1.6%
0.00%
Q1 2021$311,000
+53.2%
37,727
+26.5%
0.00%
Q4 2020$203,000
-52.6%
29,821
-22.4%
0.00%
Q3 2020$428,000
+332.3%
38,424
+143.2%
0.00%
Q2 2020$99,000
+83.3%
15,801
-45.2%
0.00%
Q1 2020$54,000
+1250.0%
28,846
+2464.1%
0.00%
Q4 2019$4,0001,125
+800.0%
0.00%
Q3 2019$0
-100.0%
125
-61.5%
0.00%
Q2 2019$1,000
-97.3%
325
-96.1%
0.00%
Q3 2018$37,000
+19.4%
8,345
+92.0%
0.00%
Q2 2018$31,000
+675.0%
4,347
+443.4%
0.00%
Q1 2018$4,000
+300.0%
800
+444.2%
0.00%
Q4 2017$1,000147
+345.5%
0.00%
Q3 2017$0
-100.0%
33
-99.3%
0.00%
Q2 2017$9,000
+125.0%
4,500
+379.7%
0.00%
Q1 2017$4,0000.0%938
+14.1%
0.00%
Q4 2016$4,000
+300.0%
822
+914.8%
0.00%
Q3 2016$1,0000.0%81
+11.0%
0.00%
Q4 2015$1,000
-90.9%
73
-94.4%
0.00%
Q3 2015$11,000
-59.3%
1,296
-15.7%
0.00%
Q2 2015$27,0001,5380.00%
Other shareholders
SORRENTO THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 6,000,000$66,900,0002.57%
SABBY MANAGEMENT, LLC 606,298$6,760,0001.01%
Virtus ETF Advisers LLC 66,851$745,0000.39%
Newbridge Financial Services Group, Inc. 26,900$300,0000.30%
Avidian Wealth Solutions, LLC 330,000$3,680,0000.28%
Spectrum Wealth Advisory Group, LLC 36,692$422,0000.27%
COWEN AND COMPANY, LLC 129,200$1,441,0000.24%
Cormorant Asset Management, LP 500,000$5,575,0000.21%
SYMMETRY PEAK MANAGEMENT LLC 27,500$307,0000.20%
Aristides Capital LLC 24,302$271,0000.19%
View complete list of SORRENTO THERAPEUTICS INC shareholders